Holen Sie sich die Stockscreener-App
8.31
8.08%
-0.73
Handel nachbörslich:
8.33
0.02
+0.24%
Schlusskurs vom Vortag:
$9.04
Offen:
$8.9
24-Stunden-Volumen:
4.22M
Relative Volume:
1.71
Marktkapitalisierung:
$1.32B
Einnahmen:
$93.95M
Nettoeinkommen (Verlust:
$-129.87M
KGV:
-9.2333
EPS:
-0.9
Netto-Cashflow:
$-202.88M
1W Leistung:
+9.06%
1M Leistung:
+16.22%
6M Leistung:
+2.59%
1J Leistung:
-39.91%
1-Tages-Spanne:
$8.20
$9.13
1-Wochen-Bereich:
$7.34
$9.75
52-Wochen-Spanne:
$5.28
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.31 | 1.44B | 93.95M | -129.87M | -202.88M | -0.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences (WVE) HD Program Unaffected by uniQure's FDA Hurdles - GuruFocus
Wave Life Sciences Hits Day High with 8.92% Surge in Stock Price - Markets Mojo
Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsBull Run & Reliable Volume Spike Trade Alerts - newser.com
Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Why Wave Life Sciences Ltd. stock appeals to analystsJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Can Wave Life Sciences Ltd. recover in the next quarterPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsGlobal Markets & Low Risk High Reward Trade Ideas - newser.com
Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Can Wave Life Sciences Ltd. rally from current levelsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Candlestick signals on Wave Life Sciences Ltd. stock todayOil Prices & Daily Momentum Trading Reports - newser.com
Heatmap analysis for Wave Life Sciences Ltd. and competitorsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com
Can Wave Life Sciences Ltd. stock deliver sustainable ROE2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade
Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com
What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com
Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo
Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena
Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat
Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st
Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN
WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan
Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire
Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):